Showing results (171-180 of 195) with videos related to
Sort By:
Pageof 20
Neurosurgery|March 17, 2000
Pallidotomy microelectrode targeting: neurophysiology-based target refinementD L Kirschman, B Milligan, S Wilkinson, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 18, 2003
Neuropsychological and quality of life outcomes 12 months after unilateral thalamic stimulation for essential tremorJ A Fields, A I Tröster, S P Woods, et al.European Journal of Neurology|February 25, 2009
Subthalamic deep brain stimulation and impulse control in Parkinson's diseaseT D Hälbig, W Tse, P G Frisina, et al.Neurology|October 26, 1999
Bilateral thalamic stimulation for the treatment of essential tremorR Pahwa, K L Lyons, S B Wilkinson, et al.Allergy and Asthma Proceedings|March 11, 2010
Human leukocyte antigen type and progression from onset of symptoms to development of asthmaMolly B Martyn, Whitney Molis, Robert M Jacobson, et al.Neurology|October 24, 2001
Essential tremor in twins: an assessment of genetic vs environmental determinants of etiologyC M Tanner, S M Goldman, K E Lyons, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experienceR M Trosch, J H Friedman, M C Lannon, et al.Annals of Neurology|February 1, 1995
Apolipoprotein E genotypes in Parkinson's disease with and without dementiaW C Koller, S L Glatt, J P Hubble, et al.Clinical Neuropharmacology|August 1, 1991
Effect of MK-458 (HPMC) in Parkinson's disease previously untreated with dopaminergic drugs. A double-blind, placebo-controlled multicenter studyW C Koller, G A Block, J E Ahlskog, et al.Neurology|January 27, 2006
Topiramate in essential tremor: a double-blind, placebo-controlled trialW G Ondo, J Jankovic, G S Connor, et al.Pageof 20